The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Peptide-Based Drug Delivery System Market Research Report 2024
Synopsis
A peptide-based drug delivery system refers to a technology or formulation that utilizes peptides to improve the delivery, targeting, and release of therapeutic drugs. These systems are designed to enhance the efficacy, bioavailability, and safety of drugs by specifically delivering them to the desired site of action in the body.
Global Peptide-Based Drug Delivery System market is projected to reach US$ 43610 million in 2029, increasing from US$ 32150 million in 2022, with the CAGR of 4.3% during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Peptide-Based Drug Delivery System market research.
Key market drivers for peptide-based drug delivery systems is the growing demand for targeted and personalized therapies. Peptides offer the advantage of high specificity and affinity for specific receptors or cell types, allowing for precise delivery of drugs to the desired sites in the body. This targeted approach enhances therapeutic efficacy while minimizing off-target effects and reducing systemic toxicity.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Peptide-Based Drug Delivery System market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Sanofi
Teva
Novo Nordisk
Takeda
Eli Lilly
AstraZeneca
Novartis
AbbVie
Ipsen
Ferring
Merck
The Medicines
Roche
J & J
Segment by Type
Brand
Generic Drug
Segment by Application
Cancer
Metabolic Disorders
Central Nervous System
Other
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Peptide-Based Drug Delivery System report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Global market size, regional market size. Market Opportunities and Challenges
Chapter 3: Companies’ Competition Patterns
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6 to 10: Country Level Value Analysis
Chapter 11: Companies’ Outline
Chapter 12: Market Conclusions
Chapter 13: Research Methodology and Data Source
A peptide-based drug delivery system refers to a technology or formulation that utilizes peptides to improve the delivery, targeting, and release of therapeutic drugs. These systems are designed to enhance the efficacy, bioavailability, and safety of drugs by specifically delivering them to the desired site of action in the body.
Global Peptide-Based Drug Delivery System market is projected to reach US$ 43610 million in 2029, increasing from US$ 32150 million in 2022, with the CAGR of 4.3% during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Peptide-Based Drug Delivery System market research.
Key market drivers for peptide-based drug delivery systems is the growing demand for targeted and personalized therapies. Peptides offer the advantage of high specificity and affinity for specific receptors or cell types, allowing for precise delivery of drugs to the desired sites in the body. This targeted approach enhances therapeutic efficacy while minimizing off-target effects and reducing systemic toxicity.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Peptide-Based Drug Delivery System market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Sanofi
Teva
Novo Nordisk
Takeda
Eli Lilly
AstraZeneca
Novartis
AbbVie
Ipsen
Ferring
Merck
The Medicines
Roche
J & J
Segment by Type
Brand
Generic Drug
Segment by Application
Cancer
Metabolic Disorders
Central Nervous System
Other
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Peptide-Based Drug Delivery System report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Global market size, regional market size. Market Opportunities and Challenges
Chapter 3: Companies’ Competition Patterns
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6 to 10: Country Level Value Analysis
Chapter 11: Companies’ Outline
Chapter 12: Market Conclusions
Chapter 13: Research Methodology and Data Source
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Peptide-Based Drug Delivery System Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Brand
1.2.3 Generic Drug
1.3 Market by Application
1.3.1 Global Peptide-Based Drug Delivery System Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Cancer
1.3.3 Metabolic Disorders
1.3.4 Central Nervous System
1.3.5 Other
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Peptide-Based Drug Delivery System Market Perspective (2018-2029)
2.2 Peptide-Based Drug Delivery System Growth Trends by Region
2.2.1 Global Peptide-Based Drug Delivery System Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Peptide-Based Drug Delivery System Historic Market Size by Region (2018-2023)
2.2.3 Peptide-Based Drug Delivery System Forecasted Market Size by Region (2024-2029)
2.3 Peptide-Based Drug Delivery System Market Dynamics
2.3.1 Peptide-Based Drug Delivery System Industry Trends
2.3.2 Peptide-Based Drug Delivery System Market Drivers
2.3.3 Peptide-Based Drug Delivery System Market Challenges
2.3.4 Peptide-Based Drug Delivery System Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Peptide-Based Drug Delivery System Players by Revenue
3.1.1 Global Top Peptide-Based Drug Delivery System Players by Revenue (2018-2023)
3.1.2 Global Peptide-Based Drug Delivery System Revenue Market Share by Players (2018-2023)
3.2 Global Peptide-Based Drug Delivery System Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Peptide-Based Drug Delivery System Revenue
3.4 Global Peptide-Based Drug Delivery System Market Concentration Ratio
3.4.1 Global Peptide-Based Drug Delivery System Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Peptide-Based Drug Delivery System Revenue in 2022
3.5 Peptide-Based Drug Delivery System Key Players Head office and Area Served
3.6 Key Players Peptide-Based Drug Delivery System Product Solution and Service
3.7 Date of Enter into Peptide-Based Drug Delivery System Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Peptide-Based Drug Delivery System Breakdown Data by Type
4.1 Global Peptide-Based Drug Delivery System Historic Market Size by Type (2018-2023)
4.2 Global Peptide-Based Drug Delivery System Forecasted Market Size by Type (2024-2029)
5 Peptide-Based Drug Delivery System Breakdown Data by Application
5.1 Global Peptide-Based Drug Delivery System Historic Market Size by Application (2018-2023)
5.2 Global Peptide-Based Drug Delivery System Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Peptide-Based Drug Delivery System Market Size (2018-2029)
6.2 North America Peptide-Based Drug Delivery System Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Peptide-Based Drug Delivery System Market Size by Country (2018-2023)
6.4 North America Peptide-Based Drug Delivery System Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Peptide-Based Drug Delivery System Market Size (2018-2029)
7.2 Europe Peptide-Based Drug Delivery System Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Peptide-Based Drug Delivery System Market Size by Country (2018-2023)
7.4 Europe Peptide-Based Drug Delivery System Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Peptide-Based Drug Delivery System Market Size (2018-2029)
8.2 Asia-Pacific Peptide-Based Drug Delivery System Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Peptide-Based Drug Delivery System Market Size by Region (2018-2023)
8.4 Asia-Pacific Peptide-Based Drug Delivery System Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Peptide-Based Drug Delivery System Market Size (2018-2029)
9.2 Latin America Peptide-Based Drug Delivery System Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Peptide-Based Drug Delivery System Market Size by Country (2018-2023)
9.4 Latin America Peptide-Based Drug Delivery System Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Peptide-Based Drug Delivery System Market Size (2018-2029)
10.2 Middle East & Africa Peptide-Based Drug Delivery System Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Peptide-Based Drug Delivery System Market Size by Country (2018-2023)
10.4 Middle East & Africa Peptide-Based Drug Delivery System Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Sanofi
11.1.1 Sanofi Company Detail
11.1.2 Sanofi Business Overview
11.1.3 Sanofi Peptide-Based Drug Delivery System Introduction
11.1.4 Sanofi Revenue in Peptide-Based Drug Delivery System Business (2018-2023)
11.1.5 Sanofi Recent Development
11.2 Teva
11.2.1 Teva Company Detail
11.2.2 Teva Business Overview
11.2.3 Teva Peptide-Based Drug Delivery System Introduction
11.2.4 Teva Revenue in Peptide-Based Drug Delivery System Business (2018-2023)
11.2.5 Teva Recent Development
11.3 Novo Nordisk
11.3.1 Novo Nordisk Company Detail
11.3.2 Novo Nordisk Business Overview
11.3.3 Novo Nordisk Peptide-Based Drug Delivery System Introduction
11.3.4 Novo Nordisk Revenue in Peptide-Based Drug Delivery System Business (2018-2023)
11.3.5 Novo Nordisk Recent Development
11.4 Takeda
11.4.1 Takeda Company Detail
11.4.2 Takeda Business Overview
11.4.3 Takeda Peptide-Based Drug Delivery System Introduction
11.4.4 Takeda Revenue in Peptide-Based Drug Delivery System Business (2018-2023)
11.4.5 Takeda Recent Development
11.5 Eli Lilly
11.5.1 Eli Lilly Company Detail
11.5.2 Eli Lilly Business Overview
11.5.3 Eli Lilly Peptide-Based Drug Delivery System Introduction
11.5.4 Eli Lilly Revenue in Peptide-Based Drug Delivery System Business (2018-2023)
11.5.5 Eli Lilly Recent Development
11.6 AstraZeneca
11.6.1 AstraZeneca Company Detail
11.6.2 AstraZeneca Business Overview
11.6.3 AstraZeneca Peptide-Based Drug Delivery System Introduction
11.6.4 AstraZeneca Revenue in Peptide-Based Drug Delivery System Business (2018-2023)
11.6.5 AstraZeneca Recent Development
11.7 Novartis
11.7.1 Novartis Company Detail
11.7.2 Novartis Business Overview
11.7.3 Novartis Peptide-Based Drug Delivery System Introduction
11.7.4 Novartis Revenue in Peptide-Based Drug Delivery System Business (2018-2023)
11.7.5 Novartis Recent Development
11.8 AbbVie
11.8.1 AbbVie Company Detail
11.8.2 AbbVie Business Overview
11.8.3 AbbVie Peptide-Based Drug Delivery System Introduction
11.8.4 AbbVie Revenue in Peptide-Based Drug Delivery System Business (2018-2023)
11.8.5 AbbVie Recent Development
11.9 Ipsen
11.9.1 Ipsen Company Detail
11.9.2 Ipsen Business Overview
11.9.3 Ipsen Peptide-Based Drug Delivery System Introduction
11.9.4 Ipsen Revenue in Peptide-Based Drug Delivery System Business (2018-2023)
11.9.5 Ipsen Recent Development
11.10 Ferring
11.10.1 Ferring Company Detail
11.10.2 Ferring Business Overview
11.10.3 Ferring Peptide-Based Drug Delivery System Introduction
11.10.4 Ferring Revenue in Peptide-Based Drug Delivery System Business (2018-2023)
11.10.5 Ferring Recent Development
11.11 Merck
11.11.1 Merck Company Detail
11.11.2 Merck Business Overview
11.11.3 Merck Peptide-Based Drug Delivery System Introduction
11.11.4 Merck Revenue in Peptide-Based Drug Delivery System Business (2018-2023)
11.11.5 Merck Recent Development
11.12 The Medicines
11.12.1 The Medicines Company Detail
11.12.2 The Medicines Business Overview
11.12.3 The Medicines Peptide-Based Drug Delivery System Introduction
11.12.4 The Medicines Revenue in Peptide-Based Drug Delivery System Business (2018-2023)
11.12.5 The Medicines Recent Development
11.13 Roche
11.13.1 Roche Company Detail
11.13.2 Roche Business Overview
11.13.3 Roche Peptide-Based Drug Delivery System Introduction
11.13.4 Roche Revenue in Peptide-Based Drug Delivery System Business (2018-2023)
11.13.5 Roche Recent Development
11.14 J & J
11.14.1 J & J Company Detail
11.14.2 J & J Business Overview
11.14.3 J & J Peptide-Based Drug Delivery System Introduction
11.14.4 J & J Revenue in Peptide-Based Drug Delivery System Business (2018-2023)
11.14.5 J & J Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
